Effects of Buprenorphine/Naloxone and Methadone on Depressive Symptoms in People with Prescription Opioid Use Disorder: A Pragmatic Randomised Controlled Trial

OBJECTIVE: This study aimed to evaluate the effectiveness of flexible take-home dosing of buprenorphine/naloxone (BUP/NX) and methadone standard model of care in reducing depressive symptoms in people with prescription-type opioid use disorder (POUD). This trial also evaluated whether improvements i...

Descripción completa

Detalles Bibliográficos
Autores principales: Bastien, Gabriel, McAnulty, Christina, Ledjiar, Omar, Socias, M. Eugenia, Le Foll, Bernard, Lim, Ron, Hassan, Ahmed N., Brissette, Suzanne, Marsan, Stéphanie, Talbot, Annie, Jutras-Aswad, Didier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411362/
https://www.ncbi.nlm.nih.gov/pubmed/36519188
http://dx.doi.org/10.1177/07067437221145013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411362/
https://www.ncbi.nlm.nih.gov/pubmed/36519188
http://dx.doi.org/10.1177/07067437221145013

Ejemplares similares